BerandaORMP • NASDAQ
add
Oramed Pharmaceuticals, Inc.
Tutup sebelumnya
$2,81
Rentang hari
$2,75 - $2,89
Rentang tahun
$1,82 - $3,23
Kapitalisasi pasar
113,44Â jt USD
Volume Rata-Rata
229,89Â rb
Rasio P/E
2,83
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 2,43Â jt | -21,43% |
Penghasilan bersih | 48,40Â jt | 346,67% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -2,40Â jt | 21,11% |
Tarif pajak efektif | 18,61% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 134,69Â jt | -5,35% |
Total aset | 220,49Â jt | 33,57% |
Total liabilitas | 18,16Â jt | 90,01% |
Total ekuitas | 202,33 jt | — |
Saham yang beredar | 39,80 jt | — |
Harga terhadap nilai buku | 0,56 | — |
Tingkat pengembalian aset | -3,18% | — |
Tingkat pengembalian modal | -3,39% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 48,40Â jt | 346,67% |
Kas dari operasi | -1,62Â jt | 77,12% |
Kas dari investasi | 38,36Â jt | 211,98% |
Kas dari pembiayaan | -361,00Â rb | 72,04% |
Perubahan kas bersih | 36,38Â jt | 185,31% |
Arus kas bebas | 589,12Â rb | 312,20% |
Tentang
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
CEO
Didirikan
2006
Situs
Karyawan
13
